import type { BlogArticle } from '../blog-types';

export const article: BlogArticle = {
  slug: "where-to-buy-ace2-peptide-fragments-research-guide",
  title: "Where to Buy ACE2 Peptide Fragments: A Researcher's Sourcing Guide",
  description:
    "What researchers need to know before sourcing ACE2-derived peptide fragments — including the key fragments studied in cardiovascular and renin-angiotensin system research, purity requirements, and COA documentation standards for these technically demanding synthetic peptides.",
  category: "Quality & Testing",
  readMinutes: 10,
  publishedAt: "2026-06-11",
  ogImage: "/og-image.jpg",
  body: [
    {
      type: "paragraph",
      text: "ACE2 (angiotensin-converting enzyme 2) is a zinc-dependent carboxypeptidase and the central regulatory enzyme of the protective arm of the renin-angiotensin system (RAS). Unlike ACE, which generates angiotensin II (Ang II, a vasoconstrictor) from angiotensin I, ACE2 cleaves Ang II to produce angiotensin-(1–7) — a peptide with vasodilatory, anti-inflammatory, and cardioprotective effects mediated through the Mas receptor. The balance between these two arms of the RAS has emerged as a critical determinant of cardiovascular outcomes, and synthetic peptide fragments derived from ACE2's catalytic domain or from its substrate/product peptides represent key research tools for studying this system.",
    },
    {
      type: "paragraph",
      text: "The ACE2 research landscape encompasses several distinct peptide classes: fragments mimicking ACE2's collectrin-like domain (relevant to protein-protein interaction studies), angiotensin-(1–7) itself and its stable analogs (Mas receptor agonists), the cyclic heptapeptide Ang-(1–7) analog AVE 0991, and inhibitory peptide fragments used to dissect ACE2 catalytic mechanisms. This guide addresses the sourcing considerations that apply across this category.",
    },
    {
      type: "heading",
      text: "The Main ACE2-Related Peptide Research Tools",
    },
    {
      type: "subheading",
      text: "Angiotensin-(1–7): Asp-Arg-Val-Tyr-Ile-His-Pro",
    },
    {
      type: "paragraph",
      text: "Ang-(1–7) is the primary ACE2 product of interest for cardiovascular research. MW: 899.02 Da. This heptapeptide activates the Mas receptor with nanomolar affinity and drives vasodilation, natriuresis, and anti-fibrotic signaling in relevant models. It is rapidly degraded in plasma (half-life ~30 seconds in circulation), which makes the in vitro and ex vivo research context where it is most practically applied. The tyrosine at position 4 is a photooxidative vulnerability; the histidine at position 6 is a pH-sensitive residue affecting solubility at extremes. Both require careful handling.",
    },
    {
      type: "subheading",
      text: "ACE2 Collectrin-Like Domain Fragments",
    },
    {
      type: "paragraph",
      text: "The collectrin-like domain of ACE2 (roughly residues 740–805) mediates its homodimerization and membrane anchoring. Synthetic fragments from this region are used in binding competition assays, structural biology studies, and protein-protein interaction research. These fragments are typically 10–20 residues in length — medium-complexity synthesis — with hydrophobic character that requires attention to aggregation state during reconstitution.",
    },
    {
      type: "subheading",
      text: "Ang-(1–7) Stable Analogs: DIZE and AVE 0991",
    },
    {
      type: "paragraph",
      text: "To overcome Ang-(1–7)'s rapid in vivo degradation, research has turned to metabolically stabilized analogs. Diminazene aceturate (DIZE) is an ACE2 activator (not an analog) used to upregulate endogenous Ang-(1–7) production. AVE 0991, a non-peptide Mas receptor agonist, is structurally unrelated to heptapeptide Ang-(1–7) but functionally analogous. For research requiring the peptide structure itself, fluorine-substituted Ang-(1–7) analogs and cyclic versions have been developed — each presenting distinct purity characterization requirements.",
    },
    {
      type: "heading",
      text: "Purity Requirements for ACE2 Peptide Research",
    },
    {
      type: "paragraph",
      text: "Given the nanomolar receptor affinities involved in Mas receptor signaling studies, ≥98% HPLC purity is the minimum for Ang-(1–7) and related heptapeptides. ACE2 pathway research involves dose-response characterization at concentrations where small changes in active peptide content translate directly to reproducibility failures. A 92% pure Ang-(1–7) lot means 8% of the weighed mass consists of degradation products and synthesis byproducts with unknown receptor pharmacology — some of which may have partial antagonist activity at the Mas receptor, directly confounding functional assays.",
    },
    {
      type: "paragraph",
      text: "For collectrin-domain fragments used in binding competition or structural studies, purity requirements depend on the specific application. Binding competition assays generally require ≥95%, while structural studies (NMR, X-ray) may require ≥99% and specific isotope labeling — which involves different synthesis entirely and is beyond standard peptide supplier scope.",
    },
    {
      type: "heading",
      text: "What a Complete ACE2 Peptide Fragment COA Should Include",
    },
    {
      type: "list",
      items: [
        "HPLC chromatogram: ≥98% purity for Ang-(1–7) and related receptor-active fragments; method parameters including C18 column specs, mobile phase, and UV wavelength (220 nm)",
        "Mass spectrometry: exact mass confirmation for each fragment — Ang-(1–7) target 899.02 Da; any deviation indicates sequence error, oxidation (+16, +32), or deamidation (+1)",
        "Tyrosine oxidation assessment for Ang-(1–7): +16 Da satellite peak at Tyr4 should be <1% of total ion current",
        "Histidine modification check: His6 deamidation or oxidation can alter Mas receptor binding — MS should confirm no +1 or +16 Da His-specific modifications",
        "Water content by Karl Fischer titration for accurate molar dosing calculations",
        "Endotoxin testing (LAL, <1.0 EU/mg) for any vascular or cardiac cell culture application",
        "Appearance: white to off-white lyophilized powder",
        "Lot number, synthesis date, and third-party laboratory attribution",
      ],
    },
    {
      type: "heading",
      text: "Synthesis Complexity Considerations",
    },
    {
      type: "paragraph",
      text: "Ang-(1–7) is a seven-residue peptide with several challenging features. The aspartic acid at position 1 (the N-terminus) is susceptible to aspartimide formation during SPPS — a cyclic imide byproduct that creates a -18 Da impurity barely separable from the main product by HPLC but functionally distinct at the Mas receptor. Suppliers using older resin chemistries or suboptimal coupling conditions will accumulate this impurity. MS is the primary detection tool — an HPLC trace that appears clean may still contain unresolved aspartimide.",
    },
    {
      type: "paragraph",
      text: "The isoleucine at position 5 has a chiral beta-carbon (two stereocenters), making racemization during synthesis a real quality risk. allo-Isoleucine (the diastereomer) produces a +0 Da MS result but alters backbone geometry and will show a shifted HPLC retention time. Vendors who report MS data without HPLC or who report HPLC data without MS cannot distinguish this failure mode. Both characterization methods are required.",
    },
    {
      type: "heading",
      text: "Reconstitution and Stability",
    },
    {
      type: "paragraph",
      text: "Ang-(1–7) is moderately soluble in sterile water or PBS at physiological pH (1–5 mg/mL). The histidine residue (pKa ~6.0) means solubility and aggregation behavior shift with pH — below pH 6, histidine protonation increases aqueous solubility; above pH 7.5, hydrophobic clustering is more likely. For cell culture applications where media pH is maintained at ~7.4, prepare Ang-(1–7) stocks in sterile water at slightly acidic pH (5.5–6.0) and dilute into media immediately before use.",
    },
    {
      type: "paragraph",
      text: "Lyophilized Ang-(1–7) stored at -20°C under inert atmosphere is stable for 18–24 months. Reconstituted solutions degrade rapidly at 37°C (relevant in any cell culture incubation) — the endogenous peptidase degradation that limits in vivo half-life to seconds also operates in vitro. For longer-duration culture experiments, peptide must be replenished regularly. This is a fundamental property of the compound, not a quality defect, but researchers sourcing Ang-(1–7) for the first time should plan experimental designs that account for it.",
    },
    {
      type: "heading",
      text: "The RAS Research Context: Why Source Quality Is Non-Negotiable",
    },
    {
      type: "paragraph",
      text: "ACE2/Ang-(1–7)/Mas axis research spans multiple high-stakes domains: heart failure models, hypertension studies, pulmonary vascular biology, and — following heightened awareness of ACE2's role as a viral receptor — COVID-19 pathology research. In all of these contexts, the experimental logic depends on precisely defined peptide concentrations at a characterized receptor system. An impure Ang-(1–7) lot introduces variables that can produce false-negative results (underpowered dose due to lower effective peptide content) or false-positive artifacts (partial Mas receptor antagonism from byproducts).",
    },
    {
      type: "paragraph",
      text: "The reproducibility problem is compounded by the fact that different research groups may be sourcing from different suppliers. If one group's Ang-(1–7) is 94% pure and another's is 99% pure, dose-matched experiments will not actually deliver the same amount of active peptide — creating the appearance of irreproducible results from studies that were actually methodologically sound. High-purity, independently verified material is a prerequisite for research that can be compared across laboratories.",
    },
    {
      type: "heading",
      text: "Red Flags in the ACE2 Peptide Fragment Market",
    },
    {
      type: "list",
      items: [
        "COA without both HPLC and MS data — the aspartimide failure mode and isoleucine diastereomer cannot be detected with only one method",
        "No tyrosine oxidation assessment — Tyr4 oxidation is the most common stability failure in Ang-(1–7)",
        "Purity <98% for receptor-active fragments used in dose-response studies",
        "No endotoxin testing for cell culture or ex vivo tissue applications involving vascular or cardiac models",
        "Supplier offering Ang-(1–7) at unusually low prices — the aspartate-first SPPS sequence and isoleucine stereocenters impose real synthesis difficulty that commodity pricing cannot support",
        "COA dated significantly before the order date without confirmed cold-chain storage documentation — these fragments degrade in stored solution",
      ],
    },
    {
      type: "heading",
      text: "Why Nexphoria",
    },
    {
      type: "paragraph",
      text: "Nexphoria's ACE2 peptide fragments — including Ang-(1–7) and related RAS research tools — are synthesized using modern Fmoc-SPPS with aspartimide-suppression resin chemistries, HPLC purity ≥99%, and full MS characterization confirming exact mass, absence of Tyr4 oxidation, and absence of aspartimide byproduct. Isoleucine stereochemistry is verified through retention time comparison against reference standards.",
    },
    {
      type: "paragraph",
      text: "For researchers working in cardiovascular biology, pulmonary vascular research, or RAS pathway studies, the quality requirements for ACE2 peptide fragments are exacting — and the published literature setting the benchmark for these studies used rigorously characterized material. We supply material that meets that benchmark.",
    },
    {
      type: "disclaimer",
      text: "ACE2 peptide fragments are sold by Nexphoria strictly for in vitro and preclinical research use. They are not approved for human consumption, therapeutic use, or veterinary application. All purchases require agreement to our research-use-only terms.",
    },
  ],
};
